Anti-Microbial Savior BioteQ Co., Ltd (6864.TWO)
TWD 78.5
(-29.28%)
TWD 78.5
(-29.28%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -77.04 Million TWD | 39.4% |
| 2022 | -127.12 Million TWD | 16.6% |
| 2021 | -152.43 Million TWD | -72.66% |
| 2020 | -88.28 Million TWD | -202.0% |
| 2019 | -29.23 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -121.33 Million TWD | -57.49% |
| 2023 FY | -77.04 Million TWD | 39.4% |
| 2023 Q4 | -77.04 Million TWD | 24.32% |
| 2023 Q2 | -101.79 Million TWD | 19.92% |
| 2022 Q4 | -127.12 Million TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 70.835% |
| Level Biotechnology Inc. | -453.9 Million TWD | 83.026% |
| Sagittarius Life Science Corp | -120.57 Million TWD | 36.1% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 60.771% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 115.413% |
| GlycoNex Incorporation | -148.56 Million TWD | 48.142% |
| VBI | -25.31 Million TWD | -204.329% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 291.338% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 155.831% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 70.659% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 351.959% |
| Visgeneer Inc. | 31.28 Million TWD | 346.273% |
| Mycenax Biotech Inc. | 207 Million TWD | 137.218% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 88.68% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 42.612% |
| Neith Corporation | -150.31 Million TWD | 48.744% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 112.396% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -33.622% |
| Enimmune corporation | -314.15 Million TWD | 75.476% |
| TaiRx, Inc. | -147.86 Million TWD | 47.897% |
| CHO Pharma, Inc. | -203.79 Million TWD | 62.195% |
| EirGenix Inc. | -4.58 Billion TWD | 98.321% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | 9.107% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 163.741% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 97.606% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 75.728% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -288.856% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 342.208% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 251.796% |
| RBC Bioscience Corporation | 422.18 Million TWD | 118.249% |
| BiOptic Inc. | 12.59 Million TWD | 711.849% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 91.842% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | 24.084% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 53.356% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 124.468% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -19.78% |
| NaviFUS Corp. | -123.12 Million TWD | 37.428% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 204.042% |
| Sinew Pharma Inc. | -160.34 Million TWD | 51.951% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 68.15% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 77.164% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 81.329% |
| AP Biosciences Inc | -196.52 Million TWD | 60.797% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 111.186% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -573.638% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 90.714% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 105.676% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 81.43% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 63.196% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | 46.446% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 76.692% |
| TCI GENE Inc. | -689.25 Million TWD | 88.822% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 35.223% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 94.115% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 476.136% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 24.37% |
| PharmaEngine, Inc. | -860.8 Million TWD | 91.05% |
| Savior Lifetec Corporation | -812.54 Million TWD | 90.518% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 74.316% |
| OBI Pharma, Inc. | -398.22 Million TWD | 80.653% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 78.916% |
| Acepodia, Inc. | -6.02 Billion TWD | 98.72% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 97.735% |